The U.S. Food and Drug Administration (FDA) has approved the cholesterol-lowering drug Crestor for kids with a genetic condition that causes high cholesterol. The condition, called heterozygous familial hypercholesterolemia, causes high levels of bad cholesterol and an increased risk for early heart disease. The FDA's move allows the use of the statin Crestor to treat children and teens ages 10 to 17 years old who have the condition.
Read full story >